Understanding Certificates of Analysis: How Third-Party Purity Testing Works
·
A Certificate of Analysis (COA) is one of the few objective tools a researcher has for verifying that a peptide sample matches its label before it’s ever used in an experiment. Yet many researchers glance at a COA’s purity percentage without understanding what the rest of the document is actually reporting. Here’s a breakdown of what goes into legitimate third-party testing.
A Certificate of Analysis (COA) confirms a peptide’s identity via mass spectrometry and its purity via HPLC, and a trustworthy COA lists the testing lab, batch number, and methodology used.
What’s Actually Tested
A thorough COA generally covers two distinct questions: is this the compound it claims to be, and how pure is it? Identity is typically confirmed using mass spectrometry, which measures the molecular weight of the sample against the expected mass of the target peptide. Purity is most commonly assessed with high-performance liquid chromatography (HPLC), which separates a sample into its component substances and quantifies what percentage corresponds to the intended peptide versus synthesis byproducts. Some COAs also include endotoxin testing, particularly relevant for compounds intended for cell culture or in vivo research models.
How to Read an HPLC Chromatogram
An HPLC report shows a series of peaks plotted against retention time. The dominant peak, ideally representing the vast majority of the area under the curve, should correspond to the target peptide. Smaller peaks indicate impurities: truncated sequences, deletion peptides, or synthesis byproducts that weren’t fully removed during purification. A clean, well-purified sample shows one clearly dominant peak with minimal background noise.
Why Third-Party Testing Matters
In-house testing is meaningful, but it doesn’t eliminate the inherent conflict of interest in a supplier verifying its own product. Independent, accredited labs with no financial stake in the result provide a meaningfully different level of assurance. Legitimate third-party COAs typically list the testing laboratory’s name, the specific batch or lot number tested, the date of testing, and the exact methodology used.
Red Flags When Evaluating a Supplier’s COA
Researchers should be cautious of COAs that list only a purity percentage with no chromatogram or supporting data, documents that don’t reference a specific batch number (making it unclear which production run was actually tested), testing dates that predate the product’s manufacture, or an absence of any identifiable testing laboratory.
Frequently Asked Questions
What’s the difference between purity and identity testing?
Identity testing (mass spectrometry) confirms the sample is the correct compound. Purity testing (HPLC) confirms how much of the sample is that compound versus impurities or byproducts.
What does a 98% purity figure actually mean?
It means that, according to HPLC analysis, roughly 98% of the peak area corresponds to the target peptide, with the remaining percentage attributed to related synthesis impurities.
Should every batch have its own COA?
Yes. Purity can vary between production runs, so a COA tied to a specific batch or lot number is far more meaningful than a general one for the product line.
Can a COA guarantee complete safety for research use?
A COA verifies identity and purity as tested, but researchers should always follow their own institution’s protocols for handling and evaluating any research compound.
BLL Peptides publishes third-party COA documentation for its products so researchers can review testing data before use in their protocols.
Disclaimer: This content is intended for research purposes only. BLL Peptides products are not intended for human consumption.
